Member Info for clairesmith

things going well since my last post, can looks like this company are now getting on to a lot of radars

bounce coming

Great big buy end of trading yesterday and looks like a lot of people are getting shares early ready for results, which based on the last should be good again, great opportunity

unfortunately the "Merger and acquisition" could be a negative if this means a share placing to finance, if its IQAI doing the buying.
really what we need is a more vocal and public facing head of the company to be installed, or have one of the current board step up. the silence is deafening.

can see a big drop coming with legacy holders looking to extract wealth as we are nearer the 2021/2022 ceiling will still in growth mode to the USA.
a happy target price to buy in is 2100 between now and September

realistically IQAI have about 2 years to really show either market dominance or wide integration and adoption before they are crushed by a Google or another growth AI Medical company.
the cost of this kind of product is the creation and certification, then the next cost is sales/marketing, but like social media once critique volume is reached it will snow ball and become ubiquitous.
the consensus in the medical industry is that AI will be the next paradigm, and IQAI as much as they have a great position now, if they don't start making waves and pushing fasting they can easily be lost in coming tsunami

It's a shame, get tech, essential need, however with TB about always fear of dilution and shares price being tanked.
until TB has fully off loaded or final converted his loans there will always be a hang over and drag down.

looking through, the companies in their portfolio that can easily see this company double in MCAP:
Lab grown leather: https://www.vitrolabsinc.com/
Eco and Healthy Pet Food: https://www.bondpets.com/our-team/
lab Sea Food: https://www.bluenalu.com/

between the 3 we are looking at multi billion dollar industries

If you across the portfolio of companies apart from the eco value, one of the main common features is that alot if the companies can scale fast and have better profit margins than the current markets they are looking to replace.
If 2 or 3 of their holding comings pop then £500m is very easy this year.

I suspect if a placing happens it would be either to get more shares of existing portfolio as they know something big is I'm the pipeline. Or to get more new companies in, which is also good as spreads the chances of an big win.

Either bodes well.

Type: Final
Dividend Amount: 10.27
Ex Date: 08/04/2021
Payment : 28/05/2021

i assume so, based on the net average trades, that MM holding the prices while old holders sell and new buy.
great chance to pick some up at a discount, have top up a few K worth day for the sunny times :)

hope everyone managed to grab their 10% profit from the bounce :)
good day, great share

looks like its knocking on the 2200 ceiling at the moment, moment it hits over it will rally to 2300 fast.
the drop after results was too strong a reaction, and the big players know that and are buying what they can at low cost.

big jump the end of the day, look to get in quick before we hit the 25's again

potentially Goldman's is a price from their overworked and stressed employees that have lost their minds due to pressure

UBS = FEVERTREE DRINKS PRICE TARGET TO 2,650 (2,750) PENCE - 'BUY'

just means domestics sales (UK Pubs, UK Bars, UK Home Drinking) will be at all time high as the money that people would have used for travel are putting into alcohol consumption, and therefore more consumption of Fevertree.

we are just in share holder churn at the moment, give this a week to rise gently with holders above 2100 threshold and then when sellers decline this will start to ramp into the spring/summer sales cycle.
fevertree is basically coming to be the biggest drink, considering all the different spirits that will be consumed with it.

havent been this low since November 2020, so a great buying opportunity.
when we are passed the sellers and profit takers leaving post sales news this should rally up fast.